General (Details) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
May 31, 2022 |
May 17, 2022 |
Sep. 30, 2022 |
Apr. 30, 2022 |
Dec. 31, 2021 |
|
General (Details) [Line Items] | |||||
Underwriter option to purchase | 462,500 | ||||
Price per share (in Dollars per share) | $ 4 | ||||
Offering expenses of payable (in Dollars) | $ 1,400 | ||||
Shares issued | 180,000 | 900,096 | 900,096 | ||
Issuance date, description | The warrants are exercisable into 294,875 of the Company’s common shares for an exercise price of $5 per share and can be exercised at any time during a period of 5 years from the issuance date (i.e. until May 17, 2027). The Warrants are classified as equity based on the guidance provided under ASC 718-10.As of the issuance date, the fair value of the warrants was estimated at $145. The valuation was based on a Black-Scholes option-pricing model, using an expected volatility of 54%, a risk-free rate of 3.01%, an expected term of 5 years, an expected dividend yield of 0% and a stock price at the issuance date of $1.95. | ||||
Warrants exercisable | 294,875 | ||||
Exercise price (in Dollars per share) | $ 5 | ||||
Estimated warrants (in Dollars) | $ 1,068 | ||||
Expected volatility, percentage | 58.00% | ||||
Common stock voting rights, description | The Company redeemed 1,783,773 shares of non-voting common stock at their par value, removing the stock from shareholders’ equity. | ||||
IPO [Member] | |||||
General (Details) [Line Items] | |||||
Aggregate shares of common stock | 4,212,500 | ||||
Expected term | 2 months 1 day | ||||
Over-Allotment Option [Member] | |||||
General (Details) [Line Items] | |||||
Net proceeds (in Dollars) | $ 15,400 | ||||
Convertible Preferred Stock [Member] | |||||
General (Details) [Line Items] | |||||
Common stock, shares issued | 7,731,083 | ||||
Convertible Preferred Stock [Member] | Common Stock [Member] | |||||
General (Details) [Line Items] | |||||
Common stock, shares issued | 1,638,161 | ||||
Black-Scholes option-pricing model [Member] | |||||
General (Details) [Line Items] | |||||
Estimated warrants (in Dollars) | $ 145 | ||||
Expected volatility, percentage | 54.00% | ||||
Risk-free rate, percentage | 3.01% | ||||
Expected term | 5 years | ||||
Expected dividend yield, percentage | 0.00% | ||||
Stock price (in Dollars per share) | $ 1.95 | ||||
Mizrahi-Tefahot Bank [Member] | |||||
General (Details) [Line Items] | |||||
Shares issued | 617,567 |
X | ||||||||||
- Definition Number of aggregate common stock shares. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Net Proceeds. No definition available.
|
X | ||||||||||
- Definition Number of underwriters shares purchased. No definition available.
|
X | ||||||||||
- Definition Warrants exercisable. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. No definition available.
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition The difference between the price paid by the public and the contract price less the related expenses. A broker-dealer may underwrite a security offering by contracting to buy the issue either at a fixed price or a price based on selling the offering on a best-effort basis. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|